All In MedTech

Device Trial Radar · NCT07371481

CTG Versus Collagen Matrix for Peri-Implant Soft Tissue Augmentation

Results of Soft Tissue Grafting Around Implant in the Mandible Molar Area

Last checked: Nov 20, 2026Latest source record: Sep 16, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

46

Planned (sponsor's estimate)

Start

Jan 1, 2026

Primary completion

Dec 2027

Study completion Sep 2028

Sponsor

Lead sponsor
Hanoi Medical UniversityAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Jan 28, 2026

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
Single (outcomes assessor)
Primary purpose
Treatment
FDA-regulated device
No
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This randomized controlled trial compares two techniques for peri-implant soft tissue augmentation in the mandibular molar region: an autogenous connective tissue graft (CTG) and a collagen matrix. Adult patients requiring implant treatment with insufficient peri-implant soft tissue thickness will be randomly assigned to receive either CTG or a collagen matrix at the time of implant surgery. The study aims to evaluate and compare changes in peri-implant soft tissue thickness, width of keratinized tissue, and soft tissue contour over a 9-month follow-up period, as well as the occurrence of postoperative complications. The results of this study will help determine whether a collagen matrix can provide clinical outcomes comparable to those of connective tissue grafting for peri-implant soft tissue augmentation.

Conditions

  • Peri-implant Soft Tissue Deficiency
  • Insufficient Peri-implant Keratinized Tissue

Interventions

  • Collagen MatrixDevice

    A porcine-derived collagen matrix is used for peri-implant soft tissue augmentation at the time of implant surgery, serving as a substitute for autogenous connective tissue grafting.

  • Connective Tissue GraftProcedure

    An autogenous connective tissue graft harvested from the patient is used for peri-implant soft tissue augmentation at the time of implant surgery.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change in peri-implant soft tissue thicknessTime frame: Baseline (before surgery) to 9 months after surgery

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • School of Dentistry, Hanoi Medical University

    Hanoi, Vietnam · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.